Mangrove Partners’s World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WQGA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100,000
Closed -$981K 601
2021
Q4
$981K Buy
+100,000
New +$58.9K 0.06% 428

Other funds holding WQGA.WS

Mangrove Partners's WQGA.WS Position: Q1 2022 in Review

Mangrove Partners sold out of World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (WQGA.WS) in Q1 2022, closing a stake of 100,000 shares — an estimated $981K sold.

Mangrove Partners first reported a position in WQGA.WS in Q4 2021 and held it in 1 quarter. The position peaked at $981K in Q4 2021. 24 funds tracked by Wall St. Rank hold WQGA.WS as of Q1 2022.

  • Mangrove Partners reported no remaining World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Mangrove Partners sold 100,000 World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $981K.
  • Mangrove Partners first reported a position in World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 1 quarter.
  • Mangrove Partners's World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $981K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.